PMC · DOI:10.3389/fmed.2024.1452812·August 6, 2024
Editorial: Engineered medicines to mitigate resistance to cancer immunotherapy
Kishu Ranjan, Prabhatchandra Dube, Sandeep Kumar Mishra
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · CAR-T cell therapy research · Immunotherapy and Immune Responses